Monoamine oxidase type B inhibitors (rasagiline, selegiline and safinamide) are a class of medications used in the management of PD, depression, anxiety disorders and panic disorder by MAO which is responsible for the metabolism of dopamine. This evidence concerns the gene MAOB and depressive disorder.